Fosun Pharma Units Get Registration Nod for Two Drugs in China

MT Newswires Live19:32

Two units of Shanghai Fosun Pharmaceutical's (HKG:2196) obtained drug registration approval for certain products from China's National Medical Products Administration, according to two Monday Hong Kong bourse filings.

Suzhou Erye Pharmaceutical's Polyethylene Glycol and Electrolytes Powder got approved for the indications of the treatment of chronic constipation in children aged one to 11 and fecal impaction in children from the age of five years.

Separately, Fosun Wanbang (Jiangsu) Pharmaceutical Group got a nod for Empagliflozin and Metformin Hydrochloride Sustained-release Tablets as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2656737515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 19:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2656737515","market":"sg","top_or_hot":-1,"title":"Fosun Pharma Units Get Registration Nod for Two Drugs in China","media":"MT Newswires Live","content":"<html><body><p> Two units of <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun</a> Pharmaceutical's (HKG:2196) obtained drug registration approval for certain products from China's National Medical Products Administration, according to two Monday Hong Kong bourse filings.</p><p>Suzhou Erye Pharmaceutical's Polyethylene Glycol and Electrolytes Powder got approved for the indications of the treatment of chronic constipation in children aged one to 11 and fecal impaction in children from the age of five years.</p><p>Separately, Fosun Wanbang (Jiangsu) Pharmaceutical Group got a nod for Empagliflozin and Metformin Hydrochloride Sustained-release Tablets as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma Units Get Registration Nod for Two Drugs in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma Units Get Registration Nod for Two Drugs in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-03 19:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Two units of <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun</a> Pharmaceutical's (HKG:2196) obtained drug registration approval for certain products from China's National Medical Products Administration, according to two Monday Hong Kong bourse filings.</p><p>Suzhou Erye Pharmaceutical's Polyethylene Glycol and Electrolytes Powder got approved for the indications of the treatment of chronic constipation in children aged one to 11 and fecal impaction in children from the age of five years.</p><p>Separately, Fosun Wanbang (Jiangsu) Pharmaceutical Group got a nod for Empagliflozin and Metformin Hydrochloride Sustained-release Tablets as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2656737515","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2656737515","pubTimestamp":1785756726,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Two units of Shanghai Fosun Pharmaceutical's  obtained drug registration approval for certain products from China's National Medical Products Administration, according to two Monday Hong Kong bourse filings.Suzhou Erye Pharmaceutical's Polyethylene Glycol and Electrolytes Powder got approved for the indications of the treatment of chronic constipation in children aged one to 11 and fecal impaction in children from the age of five years.Separately, Fosun Wanbang  Pharmaceutical Group got a nod for Empagliflozin and Metformin Hydrochloride Sustained-release Tablets as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","02196":"复星医药","BK0028":"国家队","BK0239":"医药制造","BK1515":"抗疫概念","BK1191":"制药","BK0187":"一线龙头","BK0183":"MSCI概念","BK0096":"民营医院","BK0188":"融资融券","BK1593":"医美概念股","BK0012":"证金概念","BK0175":"白马股","BK0196":"行业龙头","BK0060":"抗癌"},"translate_title":"复星医药在中国获得两种药物注册许可","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"02196":1},"content_text":"Two units of Shanghai Fosun Pharmaceutical's (HKG:2196) obtained drug registration approval for certain products from China's National Medical Products Administration, according to two Monday Hong Kong bourse filings.Suzhou Erye Pharmaceutical's Polyethylene Glycol and Electrolytes Powder got approved for the indications of the treatment of chronic constipation in children aged one to 11 and fecal impaction in children from the age of five years.Separately, Fosun Wanbang (Jiangsu) Pharmaceutical Group got a nod for Empagliflozin and Metformin Hydrochloride Sustained-release Tablets as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2656737515","isCrawlerRequest":true}